HACKENSACK, N.J.--(BUSINESS WIRE)--Progenitor Cell Therapy, LLC (PCT) announced today the addition of Mr. Paul Estrem to its Board of Managers. Mr. Estrem will replace Mr. Victor W. Schmitt as Baxter’s representative on the PCT Board. PCT benefited from Mr. Schmitt’s dedicated service on its Board from 2003 to 2007. “Victor was a staunch advocate of our corporate vision and mentor to our Executives. His guidance was appreciated and valued. We wish him continued success,” says PCT’s CEO Dr. Andrew L. Pecora.
